ClinicalTrials.gg
Sign In
Not yet recruitingNCT07904793Updated Oct 29, 2026

Care COMPASS Study

An interventional study of Guide My Care Tool in Diabetes Mellitus ( Type 1 and Type 2) and Hypertension, sponsored by Fitbit LLC. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by Fitbit LLC · Not applicable, Interventional, and Supportive care

Updated Oct 29, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This is a prospective, single-arm, mixed-methods pilot study at a single academic medical center to observe the impact, feasibility and acceptability of an AI Care Companion tool on activation and confidence among patients with chronic disease attending outpatient care.

02

Conditions studied

  • Diabetes Mellitus ( Type 1 and Type 2)
  • Hypertension
03

In context

Diabetes Mellitus

8,290 studies on the registry are indexed under Diabetes Mellitus; 1,077 are open to participants now.

This study's planned enrollment of 200 is above the median of 80 across 6,023 interventional studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

Fitbit LLC is the lead sponsor of 7 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age: Legal adult (18+)
  • Existing diagnosis of Diabetes Mellitus Type 1 / 2 and/or hypertension who have had at least two outpatient visits in the prior 12 months.
  • Scheduled in-person clinician appointment for follow up of Diabetes Mellitus -----Type 1 / 2 and/or hypertension within the next 4 months
  • Anticipate ongoing care with their current clinic for at least one month following their clinic visit for this research study.
  • Able to contact their health care team as needed (by telephone, messaging or other) in the 2 weeks following their clinic visit.
  • Able to read and write in English
  • Has an active patient portal account
  • Current user of smart phones.
  • Access to wifi or internet

Exclusion criteria

Exclusion Criteria:

  • Patients with emergency or acute medical issues arising at their scheduled appointment
  • Pregnancy (based on self-report or medical records),
  • Any other medical condition or other reason- as determined by the principal investigator or designee - that may affect participant involvement, study procedures or data collection
  • Participants who have already participated in this study.
  • Participating currently (or in the last 6 months) with a clinical trial of a health coaching intervention.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Guide My Care Tool

    Other: Guide My Care Tool

Interventions

  • OtherGuide My Care Tool

    Participants are equipped with the Guide My Care tool across three study touchpoints.

06

What researchers measure

Primary outcomes

  1. Effectiveness of a Care Companion tool

    To explore the effectiveness of a Care Companion tool on self-efficacy to manage their health related to their clinical encounter, among patients presenting to outpatient care for chronic disease management

    Time frame: 6 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 29, 2026
Show all 1 update
  1. Oct 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07904793
Lead sponsor
Fitbit LLC
Collaborators
Oregon Health and Science University
Responsible party
Sponsor
First posted
Oct 29, 2026
Start date
Oct 22, 2026 (estimated)
Primary completion
Jul 30, 2027 (estimated)
Completion
Jul 30, 2027 (estimated)
Last update
Oct 29, 2026

Study contacts

Bhavna Daryani
Contact
bhavnad@google.com
(201) 885-9852
Matthew Thompson, MD
principal investigator · Google LLC.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Diabetes Mellitus →

Other studies from this sponsor

Fitbit LLC

Start the discussion